State Ledger
Company profile

Cullinan Therapeutics, Inc. CIK 1789972

Ticker
CGEM (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, MA 02142
Fiscal year end
2025 (FY)
Market Data
Close
$14.93
Change
-$0.61
Change %
-3.89%
Volume
19,547

CGEM · trading date Oct 12, 2026 · previous close $15.54 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$219.88M
Total assets
$448.37M
Total liabilities
$39.64M
Stockholders' equity
$408.73M
Cash & equivalents
$88.33M
Operating income
-$241.65M
Operating cash flow
-$175.75M
Capital expenditures
$49.0K

Fiscal year 2025, via 10-K filed 2026-03-10. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$175.80M
Free cash flow margin
—
Liabilities / assets
8.8%
Equity / assets
91.2%
CapEx / revenue
—
Operating cash flow / net income
0.80×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$219.88M $448.37M $39.64M $408.73M
2024 — -$167.38M $621.82M $31.50M $590.33M
2023 — -$153.16M $484.18M $30.29M $453.70M
2022 $0 $111.21M $561.12M $26.09M $535.03M
2021 $18.94M -$65.57M $437.19M $11.81M $424.97M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-14
Financials filed via
Form 10-K
filed 2026-03-10

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Cambridge, MA 02142
ONE MAIN STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:35 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies